Report Detail

Pharma & Healthcare COVID-19 Impact on Global Veterinary Infectious Diseases Therapeutics Market Insights, Forecast to 2026

  • RnM4064408
  • |
  • 16 June, 2020
  • |
  • Global
  • |
  • 110 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Veterinary Infectious Diseases Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Veterinary Infectious Diseases Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Veterinary Infectious Diseases Therapeutics market is segmented into
Antibiotics
Antiviral
Antifungal
Amebicides
Anthelmintics

Segment by Application, the Veterinary Infectious Diseases Therapeutics market is segmented into
Swine
Chicken
Dog
Cat
Cow
Horse
Other

Regional and Country-level Analysis
The Veterinary Infectious Diseases Therapeutics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Veterinary Infectious Diseases Therapeutics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Veterinary Infectious Diseases Therapeutics Market Share Analysis
Veterinary Infectious Diseases Therapeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Veterinary Infectious Diseases Therapeutics business, the date to enter into the Veterinary Infectious Diseases Therapeutics market, Veterinary Infectious Diseases Therapeutics product introduction, recent developments, etc.
The major vendors covered:
Elanco Animal Health
Novartis Animal Health
Merck
Pfizer Animal Health
Sanofi
Boehringer Ingelheim Vetmedica
Dechra Animal Health
Ceva Sante Animale
Elanco Animal Health
Virbac


1 Study Coverage

  • 1.1 Veterinary Infectious Diseases Therapeutics Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Veterinary Infectious Diseases Therapeutics Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Type
    • 1.4.2 Antibiotics
    • 1.4.3 Antiviral
    • 1.4.4 Antifungal
    • 1.4.5 Amebicides
    • 1.4.6 Anthelmintics
  • 1.5 Market by Application
    • 1.5.1 Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Application
    • 1.5.2 Swine
    • 1.5.3 Chicken
    • 1.5.4 Dog
    • 1.5.5 Cat
    • 1.5.6 Cow
    • 1.5.7 Horse
    • 1.5.8 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Veterinary Infectious Diseases Therapeutics Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Veterinary Infectious Diseases Therapeutics Industry
      • 1.6.1.1 Veterinary Infectious Diseases Therapeutics Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Veterinary Infectious Diseases Therapeutics Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Veterinary Infectious Diseases Therapeutics Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Veterinary Infectious Diseases Therapeutics Market Size Estimates and Forecasts
    • 2.1.1 Global Veterinary Infectious Diseases Therapeutics Revenue 2015-2026
    • 2.1.2 Global Veterinary Infectious Diseases Therapeutics Sales 2015-2026
  • 2.2 Veterinary Infectious Diseases Therapeutics Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Veterinary Infectious Diseases Therapeutics Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Veterinary Infectious Diseases Therapeutics Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Veterinary Infectious Diseases Therapeutics Competitor Landscape by Players

  • 3.1 Veterinary Infectious Diseases Therapeutics Sales by Manufacturers
    • 3.1.1 Veterinary Infectious Diseases Therapeutics Sales by Manufacturers (2015-2020)
    • 3.1.2 Veterinary Infectious Diseases Therapeutics Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers
    • 3.2.1 Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers (2015-2020)
    • 3.2.2 Veterinary Infectious Diseases Therapeutics Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Veterinary Infectious Diseases Therapeutics Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Veterinary Infectious Diseases Therapeutics Revenue in 2019
    • 3.2.5 Global Veterinary Infectious Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Veterinary Infectious Diseases Therapeutics Price by Manufacturers
  • 3.4 Veterinary Infectious Diseases Therapeutics Manufacturing Base Distribution, Product Types
    • 3.4.1 Veterinary Infectious Diseases Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Veterinary Infectious Diseases Therapeutics Product Type
    • 3.4.3 Date of International Manufacturers Enter into Veterinary Infectious Diseases Therapeutics Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Veterinary Infectious Diseases Therapeutics Market Size by Type (2015-2020)
    • 4.1.1 Global Veterinary Infectious Diseases Therapeutics Sales by Type (2015-2020)
    • 4.1.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2015-2020)
    • 4.1.3 Veterinary Infectious Diseases Therapeutics Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Veterinary Infectious Diseases Therapeutics Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Veterinary Infectious Diseases Therapeutics Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Veterinary Infectious Diseases Therapeutics Revenue Forecast by Type (2021-2026)
    • 4.2.3 Veterinary Infectious Diseases Therapeutics Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Veterinary Infectious Diseases Therapeutics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Veterinary Infectious Diseases Therapeutics Market Size by Application (2015-2020)
    • 5.1.1 Global Veterinary Infectious Diseases Therapeutics Sales by Application (2015-2020)
    • 5.1.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2015-2020)
    • 5.1.3 Veterinary Infectious Diseases Therapeutics Price by Application (2015-2020)
  • 5.2 Veterinary Infectious Diseases Therapeutics Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Veterinary Infectious Diseases Therapeutics Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Veterinary Infectious Diseases Therapeutics Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Veterinary Infectious Diseases Therapeutics Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Veterinary Infectious Diseases Therapeutics by Country
    • 6.1.1 North America Veterinary Infectious Diseases Therapeutics Sales by Country
    • 6.1.2 North America Veterinary Infectious Diseases Therapeutics Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Veterinary Infectious Diseases Therapeutics Market Facts & Figures by Type
  • 6.3 North America Veterinary Infectious Diseases Therapeutics Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Veterinary Infectious Diseases Therapeutics by Country
    • 7.1.1 Europe Veterinary Infectious Diseases Therapeutics Sales by Country
    • 7.1.2 Europe Veterinary Infectious Diseases Therapeutics Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Veterinary Infectious Diseases Therapeutics Market Facts & Figures by Type
  • 7.3 Europe Veterinary Infectious Diseases Therapeutics Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Veterinary Infectious Diseases Therapeutics by Region
    • 8.1.1 Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Region
    • 8.1.2 Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Veterinary Infectious Diseases Therapeutics Market Facts & Figures by Type
  • 8.3 Asia Pacific Veterinary Infectious Diseases Therapeutics Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Veterinary Infectious Diseases Therapeutics by Country
    • 9.1.1 Latin America Veterinary Infectious Diseases Therapeutics Sales by Country
    • 9.1.2 Latin America Veterinary Infectious Diseases Therapeutics Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Veterinary Infectious Diseases Therapeutics Market Facts & Figures by Type
  • 9.3 Central & South America Veterinary Infectious Diseases Therapeutics Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Veterinary Infectious Diseases Therapeutics by Country
    • 10.1.1 Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Country
    • 10.1.2 Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Veterinary Infectious Diseases Therapeutics Market Facts & Figures by Type
  • 10.3 Middle East and Africa Veterinary Infectious Diseases Therapeutics Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Elanco Animal Health
    • 11.1.1 Elanco Animal Health Corporation Information
    • 11.1.2 Elanco Animal Health Description, Business Overview and Total Revenue
    • 11.1.3 Elanco Animal Health Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Products Offered
    • 11.1.5 Elanco Animal Health Recent Development
  • 11.2 Novartis Animal Health
    • 11.2.1 Novartis Animal Health Corporation Information
    • 11.2.2 Novartis Animal Health Description, Business Overview and Total Revenue
    • 11.2.3 Novartis Animal Health Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Products Offered
    • 11.2.5 Novartis Animal Health Recent Development
  • 11.3 Merck
    • 11.3.1 Merck Corporation Information
    • 11.3.2 Merck Description, Business Overview and Total Revenue
    • 11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Merck Veterinary Infectious Diseases Therapeutics Products Offered
    • 11.3.5 Merck Recent Development
  • 11.4 Pfizer Animal Health
    • 11.4.1 Pfizer Animal Health Corporation Information
    • 11.4.2 Pfizer Animal Health Description, Business Overview and Total Revenue
    • 11.4.3 Pfizer Animal Health Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Products Offered
    • 11.4.5 Pfizer Animal Health Recent Development
  • 11.5 Sanofi
    • 11.5.1 Sanofi Corporation Information
    • 11.5.2 Sanofi Description, Business Overview and Total Revenue
    • 11.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Sanofi Veterinary Infectious Diseases Therapeutics Products Offered
    • 11.5.5 Sanofi Recent Development
  • 11.6 Boehringer Ingelheim Vetmedica
    • 11.6.1 Boehringer Ingelheim Vetmedica Corporation Information
    • 11.6.2 Boehringer Ingelheim Vetmedica Description, Business Overview and Total Revenue
    • 11.6.3 Boehringer Ingelheim Vetmedica Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Products Offered
    • 11.6.5 Boehringer Ingelheim Vetmedica Recent Development
  • 11.7 Dechra Animal Health
    • 11.7.1 Dechra Animal Health Corporation Information
    • 11.7.2 Dechra Animal Health Description, Business Overview and Total Revenue
    • 11.7.3 Dechra Animal Health Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Products Offered
    • 11.7.5 Dechra Animal Health Recent Development
  • 11.8 Ceva Sante Animale
    • 11.8.1 Ceva Sante Animale Corporation Information
    • 11.8.2 Ceva Sante Animale Description, Business Overview and Total Revenue
    • 11.8.3 Ceva Sante Animale Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Products Offered
    • 11.8.5 Ceva Sante Animale Recent Development
  • 11.9 Elanco Animal Health
    • 11.9.1 Elanco Animal Health Corporation Information
    • 11.9.2 Elanco Animal Health Description, Business Overview and Total Revenue
    • 11.9.3 Elanco Animal Health Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Products Offered
    • 11.9.5 Elanco Animal Health Recent Development
  • 11.10 Virbac
    • 11.10.1 Virbac Corporation Information
    • 11.10.2 Virbac Description, Business Overview and Total Revenue
    • 11.10.3 Virbac Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Virbac Veterinary Infectious Diseases Therapeutics Products Offered
    • 11.10.5 Virbac Recent Development
  • 11.1 Elanco Animal Health
    • 11.1.1 Elanco Animal Health Corporation Information
    • 11.1.2 Elanco Animal Health Description, Business Overview and Total Revenue
    • 11.1.3 Elanco Animal Health Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Products Offered
    • 11.1.5 Elanco Animal Health Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Veterinary Infectious Diseases Therapeutics Market Estimates and Projections by Region
    • 12.1.1 Global Veterinary Infectious Diseases Therapeutics Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Veterinary Infectious Diseases Therapeutics Revenue Forecast by Regions 2021-2026
  • 12.2 North America Veterinary Infectious Diseases Therapeutics Market Size Forecast (2021-2026)
    • 12.2.1 North America: Veterinary Infectious Diseases Therapeutics Sales Forecast (2021-2026)
    • 12.2.2 North America: Veterinary Infectious Diseases Therapeutics Revenue Forecast (2021-2026)
    • 12.2.3 North America: Veterinary Infectious Diseases Therapeutics Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Veterinary Infectious Diseases Therapeutics Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Veterinary Infectious Diseases Therapeutics Sales Forecast (2021-2026)
    • 12.3.2 Europe: Veterinary Infectious Diseases Therapeutics Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Veterinary Infectious Diseases Therapeutics Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Veterinary Infectious Diseases Therapeutics Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Veterinary Infectious Diseases Therapeutics Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Veterinary Infectious Diseases Therapeutics Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Veterinary Infectious Diseases Therapeutics Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Veterinary Infectious Diseases Therapeutics Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Veterinary Infectious Diseases Therapeutics Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Veterinary Infectious Diseases Therapeutics Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Veterinary Infectious Diseases Therapeutics Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Veterinary Infectious Diseases Therapeutics Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Veterinary Infectious Diseases Therapeutics Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Veterinary Infectious Diseases Therapeutics Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Veterinary Infectious Diseases Therapeutics Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Veterinary Infectious Diseases Therapeutics Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Veterinary Infectious Diseases Therapeutics Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Veterinary Infectious Diseases Therapeutics. Industry analysis & Market Report on COVID-19 Impact on Global Veterinary Infectious Diseases Therapeutics is a syndicated market report, published as COVID-19 Impact on Global Veterinary Infectious Diseases Therapeutics Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Veterinary Infectious Diseases Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,088.80
    4,633.20
    6,177.60
    3,603.60
    5,405.40
    7,207.20
    590,031.00
    885,046.50
    1,180,062.00
    325,143.00
    487,714.50
    650,286.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report